Wesana Health Holdings, Inc. engages in the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury. It develops evidence-based formulations and protocols that empower patients to overcome neurological, psychological and mental health ailments caused by trauma. The company was founded by Daniel Carcillo, Dawn McCollough, and Chad Bronstein on October 17, 2007 and is headquartered in Chicago, IL.